Table 2.
Frequencies of individual constitutional and systemic symptoms in the overall PASC group and among the vaccinated and mAb-treated individuals
| Total PASC (n=5929)1 |
Vaccinated PASC (n=332)1 |
mAb treated PASC (n=444)1 |
|
| Constitutional symptoms: | |||
| Palpitation | 591 (10.0) | 25 (7.5) | 50 (11.3) |
| Headache | 832 (14.0) | 30 (9.0) | 52 (11.7) |
| Malaise and/or fatigue | 882 (14.9) | 42 (12.7) | 76 (17.1) |
| Systemic symptoms: | |||
| Cough | 474 (8.0) | 21 (6.3) | 41 (9.2) |
| Shortness of breath | 2578 (43.5) | 160 (50.9) | 185 (41.7) |
| Taste and/or smell changes | 74 (1.2) | 3 (0.9) | 9 (2.0) |
| Sleep disorder | 957 (16.1) | 50 (15.1) | 71 (16.0) |
| Cognitive impairment | 248 (4.2) | 17 (5.1) | 32 (7.2) |
| Mood/anxiety disorders | 1001 (16.9) | 31 (9.3) | 59 (13.3) |
* n (%).
PASC, postacute sequelae of SARS-CoV-2 infection.